,28,37,41,42 RNA-seq analyses also highlighted the relevance of DCIS recurrence classifiers (onco-type DX DCIS-, COX2+P16+ Ki67+ and 812 gene classifier) for prediction of invasive progression in untreated DCIS. This evidence concerns the gene MKI67 and ductal breast carcinoma in situ.